Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-07-10 2020-07-10
Drug Identification Number 02415437 02415437
Brand name TEVA-TRANDOLAPRIL TEVA-TRANDOLAPRIL
Common or Proper name TRANDOLAPRIL 1MG CAP TRANDOLAPRIL 1MG CAP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TRANDOLAPRIL TRANDOLAPRIL
Strength(s) 1MG 1MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-03-04 2020-03-04
Estimated end date
Actual end date 2020-03-25 2020-03-25
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Item is discontinued. Item is discontinued.
Health Canada comments